European Archives - Page 888 of 981 - European Medical Journal

EMJ

Effective Treatment of Urinary Infections Using DNA Sequencing

NOVEL DNA sequencing device has been identified as a potential tool to increase the speed and efficacy of the treatment of urinary tract infections (UTIs).

Management of Blood Pressure Control: At the Cutting Edge

Prof Williams opened the symposium by discussing the current state of blood pressure (BP) control in Europe and the key barriers to improving BP control…

When the Going Gets Tough, the Tough Get Going

Patients with elevated blood pressure (BP) represent a major problem for primary care physicians, not only because of the large number of these patients…

EMJ Cardiology 3 [Suppl 4] 2015

This satellite symposium took place on 13th June 2015 as part of the 25th European Meeting on Hypertension and Cardiovascular Protection in Milan, Italy.

EMJ

Oncimmune Appoints Dr James Jett, World Recognised Lung Cancer Specialist, as Chief Medical Officer

Nottingham, UK – 19 November 2015: Oncimmune, a leader in early cancer detection, today announced the appointment of Dr James Jett, as Chief Medical…

EMJ

Safety and Efficacy Multicentre Study of a New Multifocal Treatment to Control Acne-Prone Skin

OBJECTIVE: Assess the effectiveness and safety of a new multifocal topical method (acnelan) for acne-prone skin, using in-vitro and in-vivo studies.

EMJ

Genomics England: 100,000 Genomes Project

Clare Turnbull, MD, PhD, gives an overview of her talk at the 2015 National Cancer Research Institute (NCRI) Cancer Conference, where the Genomics…

EMJ

Reducing prostate cancer progression and mortality: what patients can do to reduce risk

Stacey Kenfield, DSc gives an overview of her talk at the 2015 National Cancer Research Institute (NCRI) Cancer Conference. Dr Kenfield talks about how…

EMJ

Helping healthcare professionals initiate conversations about physical activity

At the 2015 National Cancer Research Institute (NCRI) Cancer Conference, Justin Webb talks about the initiatives Macmillan Cancer Support is implementing…

EMJ

Two New Analyses Show Cost Effectiveness of Rifaximin-α 550mg Treatment in Belgian and Dutch Patients with Recurrent Hepatic Encephalopathy

LONDON, UK, Thursday 19 November, 07.00 GMT: Norgine B.V. has presented new analyses demonstrating the cost effectiveness of XIFAXAN® / TARGAXAN® 550…